No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Prostate Trial
Reply New Message
Back To Forum List View
Prostate Trial
7
Telepanel
Apr 24, 2020 10:26AM

Telepanel - The trial results you are looking for were News released on Dec 19th 2019. Patients on ZEN-3694 survived an average of 44 weeks longer. That news release is on the Zenith Epigenetics web page under news releases for 2019.

tada

6 Recommendations
Re: Prostate Trial
4
Telepanel
Apr 24, 2020 11:25AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply